Enjoy complimentary customisation on priority with our Enterprise License!
The rapid microbiology testing market size is forecast to increase by USD 2.48 billion, at a CAGR of 9.31% between 2022 and 2027. The market is witnessing significant growth propelled by several key factors. These include the escalating incidence of infectious diseases and cancer, which underscores the critical need for swift and accurate microbiology testing solutions. Additionally, the aging population demographic is driving demand, as older individuals are more susceptible to infections and related complications. Furthermore, the prevalence of food-borne diseases is amplifying the urgency for rapid microbiology testing methodologies to ensure food safety and public health. This confluence of factors highlights the essential role of rapid microbiology testing in safeguarding public health and advancing disease diagnostics. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample PDF
The market is poised for significant industry growth, driven by advancements in advanced technology and increasing demand for rapid tests in diagnostics. Diagnostic manufacturers are investing heavily in capital investments to develop innovative instruments, reagents, and kits for faster susceptibility testing and validation in clinical settings. This market is critical in reducing drug attrition rates through efficient clinical trials, including Phase III clinical trials, enhancing the cost-benefit ratio for healthcare providers and patients alike. Regulatory bodies play a crucial role in overseeing the quality and efficacy of IVD (in vitro diagnostics) products, ensuring compliance with rigorous standards. Companies like Illumina are at the forefront, leveraging their expertise in genomics to support small companies in developing cutting-edge microbiology testing solutions. The focus on consumables and rapid results underscores the market's commitment to improving healthcare outcomes through swift and accurate microbial detection.
The increasing incidence of infectious diseases and cancer is the key factor driving the global market. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.
A compromised immune system makes the individual susceptible to diseases such as tuberculosis and pneumonia. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly during the forecast period.
The rise in food safety concerns is the primary trend in the global market. Individual food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come into contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world.
The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, the global market report is expected to grow during the forecast period.
The inadequate healthcare services in developing regions is a major challenge to the global market. Many people in developing regions such as APAC and MEA do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by a lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as rapid microbiology testing.
The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbial testing and the subsequent treatment of infectious diseases. Hence, the drawbacks of developing countries, such as the prevalence of infectious diseases causing high mortality and morbidity, lack of skilled healthcare personnel and financial resources, and inadequate infrastructure and healthcare systems that are responsive to the needs of society, will hinder the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.
Market Customer Landscape
The market has been segmented by method, end-user, and region. In the method segment of the market, various techniques and advancements are driving efficiency and accuracy in microbiological testing. Molecular diagnostic techniques, characterized by their rapidity and precision, are gaining prominence due to ongoing technological advancements. Conference and webinar materials serve as vital resources for disseminating knowledge about emerging microbiology techniques and best practices. These platforms facilitate discussions on buying behavior and industry trends, shaping the adoption of rapid testing solutions. Key components of rapid microbiology testing include swabs, transport media, and extraction reagents. These essential tools enable the efficient collection, preservation, and processing of microbial samples, addressing food safety concerns and supporting public-private investments in microbiological research and innovation.
The market share growth of the growth-based segment will be significant during the forecast period. Growth-based rapid microbiological testing differs from traditional culture methods in that it relies on the detection of biochemical or physiological indicators. This generally allows for much faster detection, but it frequently necessitates a brief enrichment stage before microorganisms can be detected, especially in samples with low levels of contamination.
Get a glance at the market contribution of various segments Request Market Research Report Sample PDF
The growth-based segment was valued at USD 1.49 billion in 2017 and continued to grow until 2021. Growth-based microbiology testing can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of a specific microorganism, or microbial identification. The growth-based microbiology testing segment holds the largest market share in due to an increase in the early detection of infectious diseases, and it will continue to dominate the market during the forecast period.
For more insights on the market share of various regions Request Market Research Report Sample PDF
North America is projected to hold a 41% share of the market in 2023. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America was the largest revenue contributor to the global market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of microbial testing products are aiding the market. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbial testing in the region.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers solutions for rapid microbiology testing that includes a wide range of BACT/ALERT 3D culture media bottles adapted to the type of microbial detection performed.
The market report also includes detailed analyses of the competitive landscape and information about 15 companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments.
You may also interested in below market reports:
Microbiology Testing Market Microbiology Testing Market Method, Product, End-user, and Geography - Forecast and Analysis
Microbiological Testing of Water Market Microbiological Testing of Water Market by Type, End-user, and Geography - Forecast and Analysis
Bio-detection Market Bio-detection Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, Canada, UK - Size and Forecast
The market is evolving with advancements in NGS (Next-Generation Sequencing) and innovations in nucleic acid-based rapid testing methods. Regulatory bodies like the China National Drug Administration play a pivotal role in overseeing the approval and quality assurance of instrument, reagent, and kits used in clinical laboratories and other settings. Technologies such as the MiSeq Dx Sequencing System from Illumina enable precise gene testing and detection of DNA and RNA sequences, crucial for clinical disease diagnostics and biological drug testing. This market caters to a wide range of applications including beverage testing, environmental testing, and cosmetics products testing, ensuring safety and compliance with health standards. The demand for rapid testing solutions is driven by healthcare expenditure priorities and the need for swift virus detection technologies. Effective supply chain management and the availability of skilled laboratory professionals are essential for the timely delivery of diagnostic test kits and ensuring accurate results in therapeutic and environmental contexts.
Market Scope |
|
Report Coverage |
Details |
Page number |
156 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.31% |
Market growth 2023-2027 |
USD 2.48 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.07 |
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample PDF
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Method
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.